164 related articles for article (PubMed ID: 23405212)
1. Exposure of chlorpromazine to 266 nm laser beam generates new species with antibacterial properties: contributions to development of a new process for drug discovery.
Pascu ML; Danko B; Martins A; Jedlinszki N; Alexandru T; Nastasa V; Boni M; Militaru A; Andrei IR; Staicu A; Hunyadi A; Fanning S; Amaral L
PLoS One; 2013; 8(2):e55767. PubMed ID: 23405212
[TBL] [Abstract][Full Text] [Related]
2. Chlorpromazine transformation by exposure to ultraviolet laser beams in droplet and bulk.
Andrei IR; Tozar T; Dinache A; Boni M; Nastasa V; Pascu ML
Eur J Pharm Sci; 2016 Jan; 81():27-35. PubMed ID: 26432595
[TBL] [Abstract][Full Text] [Related]
3. Characterization of mixtures of compounds produced in chlorpromazine aqueous solutions by ultraviolet laser irradiation: their applications in antimicrobial assays.
Alexandru T; Staicu A; Pascu A; Radu E; Stoicu A; Nastasa V; Dinache A; Boni M; Amaral L; Pascu ML
J Biomed Opt; 2015 May; 20(5):051002. PubMed ID: 25365041
[TBL] [Abstract][Full Text] [Related]
4. Direct modification of bioactive phenothiazines by exposure to laser radiation.
Pascu ML; Nastasa V; Smarandache A; Militaru A; Martins A; Viveiros M; Boni M; Andrei IR; Pascu A; Staicu A; Molnar J; Fanning S; Amaral L
Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):147-57. PubMed ID: 21517738
[TBL] [Abstract][Full Text] [Related]
5. The in vitro activity of products formed from exposure of chlorpromazine to a 266 nm laser beam against species of mycobacteria of human interest.
Armada AM; Alexandru T; Machado D; Danko B; Hunyadi A; Dinache A; Nastasa V; Boni M; Ramos J; Viveiros M; Molnar J; Pascu ML; Amaral L
In Vivo; 2013; 27(5):605-10. PubMed ID: 23988894
[TBL] [Abstract][Full Text] [Related]
6. Interaction of solutions containing phenothiazines exposed to laser radiation with materials surfaces, in view of biomedical applications.
Simon A; Alexandru T; Boni M; Damian V; Stoicu A; Dutschk V; Pascu ML
Int J Pharm; 2014 Nov; 475(1-2):270-81. PubMed ID: 25148730
[TBL] [Abstract][Full Text] [Related]
7. Phenothiazine phototoxicity: an experimental study on chlorpromazine and its metabolites.
Ljunggren B; Möller H
J Invest Dermatol; 1977 May; 68(5):313-7. PubMed ID: 858946
[TBL] [Abstract][Full Text] [Related]
8. In vivo photodegradation of chlorpromazine.
Schoonderwoerd SA; Beijersbergen van Henegouwen GM; van Belkum S
Photochem Photobiol; 1989 Nov; 50(5):659-64. PubMed ID: 2623051
[TBL] [Abstract][Full Text] [Related]
9. FIGHTING MULTIPLE DRUG RESISTANCE: EFFECTS OF UV-ACTIVATED CHLORPROMAZINE ON RABBIT'S EYE PSEUDOTUMOURS.
Pirvulescu RA; Cherecheanu AP; Romanitan MO; Dascalu AM; Alexandrescu C
Rom J Ophthalmol; 2015; 59(1):43-7. PubMed ID: 27373115
[TBL] [Abstract][Full Text] [Related]
10. The stepwise biphotonic photoionization of chlorpromazine as seen by laser flash photolysis.
Buettner GR; Hall RD; Chignell CF; Motten AG
Photochem Photobiol; 1989 Mar; 49(3):249-56. PubMed ID: 2734362
[TBL] [Abstract][Full Text] [Related]
11. The effect of the photodecomposition of chlorpromazine on lecithin monolayers.
Nejmeh M; Pilpel N
J Pharm Pharmacol; 1978 Dec; 30(12):748-53. PubMed ID: 32237
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay for the N-oxide metabolite of chlorpromazine in human plasma and its application to a pharmacokinetic study in healthy humans.
Yeung PK; Hubbard JW; Korchinski ED; Midha KK
J Pharm Sci; 1987 Oct; 76(10):803-8. PubMed ID: 3430345
[TBL] [Abstract][Full Text] [Related]
13. Photoaddition of chlorpromazine to DNA.
Kochevar IE; Chung FL; Jeffrey AM
Chem Biol Interact; 1984 Oct; 51(3):273-84. PubMed ID: 6488389
[TBL] [Abstract][Full Text] [Related]
14. Chlorpromazine has intracellular killing activity against phagocytosed Staphylococcus aureus at clinical concentrations.
Ordway D; Viveiros M; Leandro C; Jorge Arroz M; Molnar J; Kristiansen JE; Amaral L
J Infect Chemother; 2002 Sep; 8(3):227-31. PubMed ID: 12373485
[TBL] [Abstract][Full Text] [Related]
15. Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.
Sgaragli G; Ninci R; Della Corte L; Valoti M; Nardini M; Andreoli V; Moneti G
Drug Metab Dispos; 1986; 14(2):263-6. PubMed ID: 2870904
[TBL] [Abstract][Full Text] [Related]
16. Biokinetics of chlorpromazine in primary rat and human hepatocytes and human HepaRG cells after repeated exposure.
Broeders JJ; Parmentier C; Truisi GL; Jossé R; Alexandre E; Savary CC; Hewitt PG; Mueller SO; Guillouzo A; Richert L; van Eijkeren JC; Hermens JL; Blaauboer BJ
Toxicol In Vitro; 2015 Dec; 30(1 Pt A):52-61. PubMed ID: 25458484
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the antibacterial activity of Ag-NPs conjugated with a specific antibody against Staphylococcus aureus after photoactivation.
Al-Sharqi A; Apun K; Vincent M; Kanakaraju D; Bilung LM; Sum MSH
J Appl Microbiol; 2020 Jan; 128(1):102-115. PubMed ID: 31596989
[TBL] [Abstract][Full Text] [Related]
18. Photoaddition to DNA by nonintercalated chlorpromazine molecules.
Kochevar IE; Garcia C; Geacintov NE
Photochem Photobiol; 1998 Nov; 68(5):692-7. PubMed ID: 9825699
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of chlorpromazine by stimulated human polymorphonuclear leukocytes. Induction of covalent binding of chlorpromazine to nucleic acids and proteins.
Kelder PP; de Mol NJ; 'T Hart BA; Janssen LH
Chem Biol Interact; 1991; 79(1):15-30. PubMed ID: 1647886
[TBL] [Abstract][Full Text] [Related]
20. Fate of the drug chlorpromazine in river water according to laboratory assays. Identification and evolution over time of degradation products. Sorption to sediment.
Jiménez JJ; Muñoz BE; Sánchez MI; Pardo R; Vega MS
Chemosphere; 2016 Nov; 162():285-92. PubMed ID: 27513549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
